tradingkey.logo
tradingkey.logo
Search

Bio Rad Laboratories Inc

BIO
Add to Watchlist
381.570USD
+12.570+3.41%
Close 11-06 16:00(ET)
10.20BMarket Cap
63.38P/E TTM
After-hours 19:00 (ET)381.570USD-0.510-0.13%

Today

+3.41%

5 Days

+2.52%

1 Month

+3.45%

6 Months

+47.31%

Year to Date

+25.93%

1 Year

+24.47%

Key Figures

364.450Open
384.620High
22.64KVolume
63.38P/E TTM
36.27P/E Dynamic
--Dividend TTM
0.09%Turnover Ratio
369.000Prev. Close
363.590Low
8.63MTurnover
LossP/E Static
1.18P/B
0.00%Div Yield TTM
1.75%ROA
396.23052wk High
0.09Volume Ratio
-1.84BNet Profit
26.74MShares
6.0298EPS TTM
1.09Beta
2.50%ROE
236.73052wk Low
8.79%Amplitude
53.82%Gross Margin
10.20BMarket Cap
9.52Reward/Risk
2.29%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

Bio Rad Laboratories Inc's Score

0.06vs previous score
Forecast6.00
Financial Health8.02
Technical3.34
Valuation Dimensions8.58
Institutional Confidence7.00
Risk Assessment7.71

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
362.500Target Price
-2.60%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy00000011
Buy11222222
Hold12333433
Sell11111000
Strong Sell00000000

Bio Rad Laboratories Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy

Bio Rad Laboratories Inc Latest Earnings Call Transcripts

Bio-Rad (BIO) Q3 2026 Earnings Call: ddPCR Growth and Margin Expansion

Bio-Rad’s Q3 2026 earnings call covered $656 million in revenue, ddPCR instrument growth above 20%, margin expansion and reaffirmed 2026 guidance.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
17.12/2.23
Revenue / Forecast
656.40M/649.95M

Bio Rad Laboratories Inc Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolBIO
Number of employees7700
CountryUnited States of America

Ownership

ShareholdersProportion
First Eagle Investment Management, L.L.C.11.85%
Alice N. Schwartz Revocable Trust8.21%
BlackRock Institutional Trust Company, N.A.6.73%
Schwartz (Norman D)6.36%
Shareholder TypesProportion
Investment Advisor/Hedge Fund44.15%
Investment Advisor40.11%
Individual Investor8.27%
Corporation8.21%

FAQs

What is the current price of Bio Rad Laboratories Inc (BIO)?

The current price of Bio Rad Laboratories Inc (BIO) is 381.57.

What is the symbol of Bio Rad Laboratories Inc?

The ticker symbol of Bio Rad Laboratories Inc is BIO.

What is the 52-week high of Bio Rad Laboratories Inc?

The 52-week high of Bio Rad Laboratories Inc is 396.23.

What is the 52-week low of Bio Rad Laboratories Inc?

The 52-week low of Bio Rad Laboratories Inc is 236.73.

What is the market capitalization of Bio Rad Laboratories Inc?

The market capitalization of Bio Rad Laboratories Inc is 10.20B.

Is Bio Rad Laboratories Inc (BIO) currently rated as Buy, Hold, or Sell?

According to analysts, Bio Rad Laboratories Inc (BIO) has an overall rating of signal_hold, with a price target of 362.50.

What is the Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIO)?

The Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIO) is 6.03.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.